Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Pemetrexed Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / Pharma & Healthcare / Global Pemetrexed Market

Global Pemetrexed Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

Pharma & Healthcare Jun 2020 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Pemetrexed Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

Extent Research has added a report on global Pemetrexed Market in addition to its collection of industry research reports that offers wide-ranging and in-depth up-to-date and future market trends in the global and regional market. The report covers the overall growth analysis, industrial strategic policies, market revenue, share, size, and other market growth stimulators.

Data provided by Extent Research. Source: https://www.extentresearch.com/pemetrexed-market

The Pemetrexed market report also delivers other essential market aspects such as geographical distribution which includes North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Furthermore, the detailed market dynamics coupled with restraining factors and opportunities also well mentioned in the report. The latest developmental trends and future market prospects that are likely to spearhead current product demand and future status of this market are elaborately comprehended. The basic approach of our report is to provide answers to all the Pemetrexed market-related questions for future decision-making. Further, to validate and speed up the data collection process, our analysts have used primary & secondary resources along with few of the accurate market analysis tools.

In addition, the report demonstrates the up-to-the-minute industry activities and value chain analysis for the Pemetrexed Market. Moreover, the details including new market entrants, supply & demand chain analysis, and other market competitive factors offer better insights on the growth rate over the forecast period.

Global Pemetrexed market: Competitive Landscape

The market research report provides the competitive landscape of the global Pemetrexed market along with the market share and status of all the key players in the industry. This section in the report basically describes the strategic analysis that the players are using to sustain and enhance their performance in the market in terms of revenue and regional attractiveness. Some of the key players thriving in the Pemetrexed industry include Eli Lilly, Abbott Laboratories, Cadila Healthcare, Eagle Pharmaceuticals, Stada Arzneimittel, .

Segmentation of the Global Pemetrexed Market:

By Product type

  • 100mg, 500mg,

by Application

  • Hospital Pharmacies, Retail Pharmacies, Online Pharmacies,

Key questions answered in the global Pemetrexed market report:

  • What is the expected overall market size over the forecast period?
  • Which is the region with highest product demand?
  • What are the major factors driving the growth of the market?
  • What are the opportunities and challenges faced by the key market players?
  • What are the business strategies opted by the competitive players to sustain in the market?

Report Scope and Market Segmentation

ATTRIBUTES Global Pemetrexed Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Pemetrexed Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Study Coverage 1.1 Pemetrexed Product Introduction 1.2 Market by Type 1.2.1 Global Pemetrexed Market Size Growth Rate by Type, 2017 VS 2021 VS 2035 1.2.2 100mg 1.2.3 500mg 1.3 Market by Application 1.3.1 Global Pemetrexed Market Size Growth Rate by Application, 2017 VS 2021 VS 2035 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Pemetrexed Sales Estimates and Forecasts 2017-2035 2.2 Global Pemetrexed Revenue Estimates and Forecasts 2017-2035 2.3 Global Pemetrexed Revenue by Region: 2017 VS 2021 VS 2035 2.4 Global Pemetrexed Sales by Region 2.4.1 Global Pemetrexed Sales by Region (2017-2022) 2.4.2 Global Sales Pemetrexed by Region (2023-2035) 2.5 Global Pemetrexed Revenue by Region 2.5.1 Global Pemetrexed Revenue by Region (2017-2022) 2.5.2 Global Pemetrexed Revenue by Region (2023-2035) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Pemetrexed Sales by Manufacturers 3.1.1 Global Top Pemetrexed Manufacturers by Sales (2017-2022) 3.1.2 Global Pemetrexed Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pemetrexed in 2021 3.2 Global Pemetrexed Revenue by Manufacturers 3.2.1 Global Pemetrexed Revenue by Manufacturers (2017-2022) 3.2.2 Global Pemetrexed Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Pemetrexed Revenue in 2021 3.3 Global Pemetrexed Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Pemetrexed Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Pemetrexed Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Pemetrexed Sales by Type 4.1.1 Global Pemetrexed Historical Sales by Type (2017-2022) 4.1.2 Global Pemetrexed Forecasted Sales by Type (2023-2035) 4.1.3 Global Pemetrexed Sales Market Share by Type (2017-2035) 4.2 Global Pemetrexed Revenue by Type 4.2.1 Global Pemetrexed Historical Revenue by Type (2017-2022) 4.2.2 Global Pemetrexed Forecasted Revenue by Type (2023-2035) 4.2.3 Global Pemetrexed Revenue Market Share by Type (2017-2035) 4.3 Global Pemetrexed Price by Type 4.3.1 Global Pemetrexed Price by Type (2017-2022) 4.3.2 Global Pemetrexed Price Forecast by Type (2023-2035) 5 Market Size by Application 5.1 Global Pemetrexed Sales by Application 5.1.1 Global Pemetrexed Historical Sales by Application (2017-2022) 5.1.2 Global Pemetrexed Forecasted Sales by Application (2023-2035) 5.1.3 Global Pemetrexed Sales Market Share by Application (2017-2035) 5.2 Global Pemetrexed Revenue by Application 5.2.1 Global Pemetrexed Historical Revenue by Application (2017-2022) 5.2.2 Global Pemetrexed Forecasted Revenue by Application (2023-2035) 5.2.3 Global Pemetrexed Revenue Market Share by Application (2017-2035) 5.3 Global Pemetrexed Price by Application 5.3.1 Global Pemetrexed Price by Application (2017-2022) 5.3.2 Global Pemetrexed Price Forecast by Application (2023-2035) 6 North America 6.1 North America Pemetrexed Market Size by Type 6.1.1 North America Pemetrexed Sales by Type (2017-2035) 6.1.2 North America Pemetrexed Revenue by Type (2017-2035) 6.2 North America Pemetrexed Market Size by Application 6.2.1 North America Pemetrexed Sales by Application (2017-2035) 6.2.2 North America Pemetrexed Revenue by Application (2017-2035) 6.3 North America Pemetrexed Market Size by Country 6.3.1 North America Pemetrexed Sales by Country (2017-2035) 6.3.2 North America Pemetrexed Revenue by Country (2017-2035) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Pemetrexed Market Size by Type 7.1.1 Europe Pemetrexed Sales by Type (2017-2035) 7.1.2 Europe Pemetrexed Revenue by Type (2017-2035) 7.2 Europe Pemetrexed Market Size by Application 7.2.1 Europe Pemetrexed Sales by Application (2017-2035) 7.2.2 Europe Pemetrexed Revenue by Application (2017-2035) 7.3 Europe Pemetrexed Market Size by Country 7.3.1 Europe Pemetrexed Sales by Country (2017-2035) 7.3.2 Europe Pemetrexed Revenue by Country (2017-2035) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Pemetrexed Market Size by Type 8.1.1 Asia Pacific Pemetrexed Sales by Type (2017-2035) 8.1.2 Asia Pacific Pemetrexed Revenue by Type (2017-2035) 8.2 Asia Pacific Pemetrexed Market Size by Application 8.2.1 Asia Pacific Pemetrexed Sales by Application (2017-2035) 8.2.2 Asia Pacific Pemetrexed Revenue by Application (2017-2035) 8.3 Asia Pacific Pemetrexed Market Size by Region 8.3.1 Asia Pacific Pemetrexed Sales by Region (2017-2035) 8.3.2 Asia Pacific Pemetrexed Revenue by Region (2017-2035) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Pemetrexed Market Size by Type 9.1.1 Latin America Pemetrexed Sales by Type (2017-2035) 9.1.2 Latin America Pemetrexed Revenue by Type (2017-2035) 9.2 Latin America Pemetrexed Market Size by Application 9.2.1 Latin America Pemetrexed Sales by Application (2017-2035) 9.2.2 Latin America Pemetrexed Revenue by Application (2017-2035) 9.3 Latin America Pemetrexed Market Size by Country 9.3.1 Latin America Pemetrexed Sales by Country (2017-2035) 9.3.2 Latin America Pemetrexed Revenue by Country (2017-2035) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Pemetrexed Market Size by Type 10.1.1 Middle East and Africa Pemetrexed Sales by Type (2017-2035) 10.1.2 Middle East and Africa Pemetrexed Revenue by Type (2017-2035) 10.2 Middle East and Africa Pemetrexed Market Size by Application 10.2.1 Middle East and Africa Pemetrexed Sales by Application (2017-2035) 10.2.2 Middle East and Africa Pemetrexed Revenue by Application (2017-2035) 10.3 Middle East and Africa Pemetrexed Market Size by Country 10.3.1 Middle East and Africa Pemetrexed Sales by Country (2017-2035) 10.3.2 Middle East and Africa Pemetrexed Revenue by Country (2017-2035) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Corporation Information 11.1.2 Eli Lilly Overview 11.1.3 Eli Lilly Pemetrexed Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Eli Lilly Pemetrexed Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Eli Lilly Recent Developments 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Corporation Information 11.2.2 Abbott Laboratories Overview 11.2.3 Abbott Laboratories Pemetrexed Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Abbott Laboratories Pemetrexed Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Abbott Laboratories Recent Developments 11.3 Cadila Healthcare 11.3.1 Cadila Healthcare Corporation Information 11.3.2 Cadila Healthcare Overview 11.3.3 Cadila Healthcare Pemetrexed Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Cadila Healthcare Pemetrexed Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Cadila Healthcare Recent Developments 11.4 Eagle Pharmaceuticals 11.4.1 Eagle Pharmaceuticals Corporation Information 11.4.2 Eagle Pharmaceuticals Overview 11.4.3 Eagle Pharmaceuticals Pemetrexed Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Eagle Pharmaceuticals Pemetrexed Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Eagle Pharmaceuticals Recent Developments 11.5 Stada Arzneimittel 11.5.1 Stada Arzneimittel Corporation Information 11.5.2 Stada Arzneimittel Overview 11.5.3 Stada Arzneimittel Pemetrexed Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Stada Arzneimittel Pemetrexed Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Stada Arzneimittel Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Pemetrexed Industry Chain Analysis 12.2 Pemetrexed Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Pemetrexed Production Mode & Process 12.4 Pemetrexed Sales and Marketing 12.4.1 Pemetrexed Sales Channels 12.4.2 Pemetrexed Distributors 12.5 Pemetrexed Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Pemetrexed Industry Trends 13.2 Pemetrexed Market Drivers 13.3 Pemetrexed Market Challenges 13.4 Pemetrexed Market Restraints 14 Key Findings in The Global Pemetrexed Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/pemetrexed-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/pemetrexed-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors